Routine cytological examination of vaginal and cervical smears is now an established method of early detection of cancer of the uterine cervix, and the need for screening as many women at risk as possible has been repeatedly stressed in recent leading articles (British Medical Journal, 1962, 1963, 1964, 1965; Lancet, 1963). Trichomonas vaginalis may be identified in smears stained by the Papani...

BACKGROUND Despite the significant burden of cervical cancer, Malaysia like many middle-income countries relies on opportunistic cervical screening as opposed to a more organized population-based program. The aim of this study was to ascertain the effectiveness of a worksite screening initiative upon Papanicolaou smear test (Pap test) uptake among educated working women in Malaysia. METHODS 4...

Papanicolaou test or better known as Pap test is the most popular and effective screening test for cervical cancer. At time, however, the detection of abnormal or cancerous cervical cells can be missed due to technical and human errors. In certain cases, the Pap smear images are blurred and highly affected by unwanted noises. These factors can hide and obscure the important cervical cells morph...

Objective: The primary objective of this research work is to develop a novel benchmark database of digitized and calibrated, cervical cells obtained from slides of Papanicolaou smear test, which is done for screening of cervical cancer. This database can serve as a potential tool for designing, developing, training, testing and validating various Artificial intelligence based systems for progno...

The Papanicolou screen (“Pap smear”) was developed in 1928 by Dr. George Papanicolaou for the identification of cervical cancers. It became widely known after his publication in 1941 and widely used in clinical practice in the 1950s; it is now the most commonly performed cancer screening test world-wide (1). This has been one of the most successful cancer screening techniques in modern medicine...

BACKGROUND The purpose of this study is to describe the prevalence of Papanicolaou (Pap) smear use for cervical cancer screening and to estimate its association with type of health care insurance. METHODS A cross-sectional study using data from the Health, Well-Being and Aging in Latin America and the Caribbean Study (SABE). The sample includes 6357 women aged 60 and older from seven cities. ...

Human papilloma virus (HPV) is a public health problem as a sexually transmitted disease and as a critical factor in the pathogenesis of various cancers. The clinical manifestations, epidemiology, and virology that are critical to understanding the process of cervical dysplasia and neoplasia are reviewed. A discussion of the cervical transformation zone and the classification of cervical dyspla...

BACKGROUND & OBJECTIVES Majority of cases of cervical cancer are diagnosed at an advanced stage as cytology based screening programmes are ineffective in developing countries. The present study was done to look for carcinoma cervix and its precursors by visual inspection with Lugol's iodine (VILI), visual inspection with acetic acid (VIA) and Papanicolaou smear, and to analyse their sensitivity...

Cervical cancer is the second type of that most affects women, considered a serious public health problem, however it can be detected and treated early through Pap smear. This research aimed to analyze knowledge, attitude practices biomedicine students on A cross-sectional study Knowledge, Attitude Practice (KAP), applied with 108 students, was carried out at Higher Education Institution in Ter...

Atypical glandular cells on Papanicolaou smears are an unusual but important cytologic diagnosis. The Bethesda system classifies atypical glandular cells of undetermined significance (AGUS) as glandular cells that demonstrate nuclear atypia appearing to exceed reactive or reparative changes but lacking unequivocal features of adenocarcinoma. AGUS occurs in approximately 0.18 to 0.74 percent of ...